PREDICTIVE VALUE OF INTERLEUKIN-22 AND INTERLEUKIN-17А LEVELS IN YOUNG CHILDREN WITH RECURRENT URTICARIA
Main Article Content
Abstract
The aim of the research – to determine the prognostic value of IL-22, IL-17A of young children with recurrent acute urticaria as criteria for the severity of atopic dermatitis.
Materials and methods. We analyzed the results of examination of 67 children with atopic dermatitis aged 1 to 3 years with a history (anamnesis) of atopic dermatitis, the length of the underlying disease for at least 6 months, the presence of at least two episodes of acute urticaria in the history. The concentration levels of IL-22, IL-17A were determined.
Results. Significant changes in cytokines of children with atopic dermatitis take place and, based on their results, the severity of the disease can be predicted.
Conclusion. The identification of known and the discovery of new interleukins in various diseases is important for determining the severity of the disease and predicting the development of the disease.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Mochulskaya ON, Kosovskaya TM. Systemic therapy of allergic dermatoses in children. Мodern pediatrics. Ukraine. 2021; 1(113): 62-67. Russian (Мочульская О.Н., Косовская Т.М. Системная терапия аллергодерматозов у детей //Современная педиатрия. Украина. 2021. № 1. С. 62-69)
Ozceker D, Haslak F, Dilek F, Sipahi S, Yucel E, Guler N, Tamay Z. Contact sensitization in children with atopic dermatitis. Allergol Immunopathol (Madr). 2019; 47(1): 47-51. doi: 10.1016/j.aller.2018.06.002
Luss LV. The causes and treatment of urticaria in children. Medical Council. 2015; (14): 90-93. Russian (Лусс Л.В. Причины возникновнения и лечение крапивницы у детей //Медицинский совет. 2015. № 14. С. 90-93)
Perevoshchikova NK, Gladkov SF, Pichugina YuS, Surkova MA, Chernykh NS. Early postnatal correction of the intestinal microbiota as a main factor of primary prevention of atopy. Mother and Baby in Kuzbass. 2021; № 1(84): 108-127. Russian (Перевощикова Н.К., Гладков С.Ф., Пичугина Ю.С., Суркова М.А., Черных Н.С. Ранняя постнатальная коррекция микробиоты кишечника, как главный фактор первичной профилактики атопии //Мать и Дитя в Кузбассе. 2021. № 1(84). С. 108-127)
Bashkina OA, Samotrueva MA, Pahnova LR. Clinical diagnostic and predictive value of serum IL-22 in children with atopic dermatitis. RMJ. 2019; 3: 15-18. Russian (Башкина О.А., Самотруева М.А., Пахнова Л.Р. Клинико-диагностическое и прогностическое значение уровня интерлейкина-22 в сыворотке крови у детей с атопическим дерматитом //РМЖ. 2019. № 3. С. 15-18)
Varlamov EE, Elisyutina OG, Vinogradova TV. Pathogenetic features of the cytokine profile in patients with atopic dermatitis, depending on age. Russian Journal of Allergy. 2016; 4-5: 37-42. Russian (Варламов Е.Е., Елисютина О.Г., Виноградова Т.В. Патогенетические особенности цитокинового профиля у пациентов с атопическим дерматитом в зависимости от возраста //Российский аллергологический журнал. 2016. № 4-5. С. 37-42)
La Manna S, Scognamiglio PL, Di Natale C. Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces. Biochimie. 2017; 138: 106-115
Shabgah AG, Navashenaq JG, Shabgah OG. Interleukin-22 in human inflammatory diseases and viral infections. Autoimmun Rev. 2017; 16(12):1209-1218
Cordoro KM, Hitraya-Low M, Taravati K. Skin-infiltrating, interleukin-22-producing T-cells differentiate pediatric psoriasis from adult psoriasis. J Am Acad Dermatol. 2017; 77(3): 417-424
Stefanich EG, Rae J, Sukumaran S. Pre-clinical and translational pharmacology of a human interleukin-22 IgG fusion protein for potential treatment of infectious or inflammatory diseases. Biochem Pharmacol. 2018; 152: 224-235
Sabat R, Ouyang W, Wolk K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov. 2014; 13: 21-38
Shen H, Zeng B, Wang C. MiR-330 inhibits IL-22-induced keratinocyte proliferation through targeting CTNNB1. Biomed Pharmacother. 2017; 91: 803-811
Fawbert K, Leech S. Recurrent urticaria and angioedema. Paediatrics and Child Health. 2020; 30(7): 243-248
Elisyutina OG, Fedenko ES, Boldyreva MN, Gudima GO. Features of the immune response and the role of some cytokines in atopic dermatitis. Russian Journal of Allergy. 2015; 1: 3–14. Russian (Елисютина О.Г., Феденко Е.С., Болдырева М.Н., Гудима Г.О. Особенности иммунного ответа и роль некоторых цитокинов при атопическом дерматите //Российский аллергологический журнал. 2015. № 1. 3-14)